Article by
Dan Liljenquist, Ge Bai & Gerard F. Anderson
A consortium of hospitals and health plans is establishing a nonprofit generic-drug manufacturer to produce a steady supply of affordable essential drugs and stimulate competition in generic-drug markets.
Article by
William H. Shrank, Diane Holder & Steven D. Shapiro
UPMC’s payer-provider partnership integrates real-time data to support improved clinical decision-making and optimizes clinical and financial performance.
Article by
Michael L. Millenson
The use of psychographic data by health systems and health plans could provoke a backlash if not done with patient consent.
Article by
Karen E. Joynt Maddox
Understanding APMs’ potential consequences for vulnerable populations is critical if we wish to maximize benefits and reduce harms.
Article by
Denis A. Cortese, Natalie Landman & Robert K. Smoldt
Given its clout and experience, CMS is uniquely positioned to lead the U.S. health system toward high-value care. Bundled pricing based on real costs, leveraging lessons from DRG implementation, would establish the right types of provider incentives.
Article by
Bob Kocher & Christopher J. Chen
Embracing two-sided risk while adopting workflow redesign and reviewing benchmarks is leading to improved clinical and financial outcomes.
Roundtable by
Steven Seltzer, Andrew Menard, Clayton M. Christensen & Edward Prewitt
NEJM Catalyst hosted clinical and business leaders, along with the originator of “disruptive innovation,” to consider the user frustration, high cost, and lack of interoperability of electronic medical records.
Roundtable by
Steven Seltzer, Andrew Menard, Clayton M. Christensen & Edward Prewitt
NEJM Catalyst hosted clinical and business leaders, along with the originator of “disruptive innovation,” to consider the user frustration, high cost, and lack of interoperability of electronic medical records.
Will Amazon–Berkshire Hathaway–JP Morgan and CVS-Aetna change the health care game? To one health care employer purchaser, these announcements feel a lot like Groundhog Day.
We have to think about how much we want to spend on health according to how much it’s worth to us at the margin.
Your email address will not be published. Required fields are marked *
Note: This is a moderated forum and all comments are reviewed before posting. By clicking on the "Post Comment" button below, you agree to abide by the NEJM Catalyst Terms of Use. We reserve the right to not post every comment; including those that are submitted anonymously or that are potentially illegal, vulgar, libelous, or commercial in nature.
Marje Murray
This is a very interesting slide but I would love to see the countries ranked by health outcomes and this combined spending.
April 06, 2016 at 10:44 am
Jean Barry, PhD, RN, NEA-BC
This is an outstanding piece of information in that it provides a context for our health care spending. An expanded point of view on our challenging healthcare issues is provided. Thank you so much.
Jean Barry, PdD, RN, NEA-BC
April 07, 2016 at 9:16 am
Adrienne Faerber
This is the argument that Bradley and her coauthor Lauren Taylor make in their book, "The American Healthcare Paradox" which includes an analysis of combined social + health spending and health outcomes. http://www.amazon.com/The-American-Health-Care-Paradox/dp/1610392094
April 11, 2016 at 11:09 am